Kuwano, Takashi
Miura, Shin-ichiro
Norimatsu, Kenji
Arimura, Tadaaki
Shiga, Yuhei
Tomita, Sayo
Nakayama, Asuka
Matsuo, Yoshino
Imaizumi, Satoshi
Saku, Keijiro
Article History
Received: 4 January 2016
Revised: 24 June 2016
Accepted: 6 September 2016
First Online: 13 October 2016
Competing interests
: KS is the Chief Director and SM is the Director of NPO Clinical and Applied Science, Fukuoka, Japan. KS has Endowed Department of Molecular Cardiovascular Therapeutics funding supported by MSD. SM belongs to the Department of Molecular Cardiovascular Therapeutics, which is supported by MSD. The remaining authors declare no conflict of interest.
Free to read: This content has been made available to all.